Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy

Int J Mol Sci. 2021 May 11;22(10):5063. doi: 10.3390/ijms22105063.

Abstract

Rutin is a flavonoid with antioxidant property. It has been shown to exert cardioprotection against cardiomyocyte hypertrophy. However, studies regarding its antihypertrophic property are still lacking, whether it demonstrates similar antihypertrophic effect to its metabolite, quercetin. Hence, this study aimed to investigate the effects of both flavonoids on oxidative stress and mitogen-activated protein kinase (MAPK) pathway in H9c2 cardiomyocytes that were exposed to angiotensin II (Ang II) to induce hypertrophy. Cardiomyocytes were exposed to Ang II (600 nM) with or without quercetin (331 μM) or rutin (50 μM) for 24 h. A group given vehicle served as the control. The concentration of the flavonoids was chosen based on the reported effective concentration to reduce cell hypertrophy or cardiac injury in H9c2 cells. Exposure to Ang II increased cell surface area, intracellular superoxide anion level, NADPH oxidase and inducible nitric oxide synthase activities, and reduced cellular superoxide dismutase activity and nitrite level, which were similarly reversed by both rutin and quercetin. Rutin had no significant effects on phosphorylated proteins of extracellular signal-related kinases (ERK1/2) and p38 but downregulated phosphorylated c-Jun N-terminal kinases (JNK1/2), which were induced by Ang II. Quercetin, on the other hand, had significantly downregulated the phosphorylated proteins of ERK1/2, p38, and JNK1/2. The quercetin inhibitory effect on JNK1/2 was stronger than the rutin. In conclusion, both flavonoids afford similar protective effects against Ang II-induced cardiomyocyte hypertrophy, but they differently modulate MAPK pathway.

Keywords: ERK; JNK; cardiomyocyte hypertrophy; flavonoids; inducible nitric oxide synthase; p38 kinase.

MeSH terms

  • Angiotensin II / toxicity*
  • Animals
  • Antioxidants / pharmacology
  • Cells, Cultured
  • Gene Expression Regulation, Enzymologic / drug effects*
  • Hypertrophy / chemically induced
  • Hypertrophy / drug therapy
  • Hypertrophy / metabolism*
  • Hypertrophy / pathology
  • Mitogen-Activated Protein Kinases / genetics
  • Mitogen-Activated Protein Kinases / metabolism*
  • Myoblasts, Cardiac / cytology
  • Myoblasts, Cardiac / drug effects
  • Myoblasts, Cardiac / metabolism*
  • NADPH Oxidases / metabolism
  • Nitric Oxide / metabolism
  • Phosphorylation
  • Quercetin / pharmacology*
  • Rats
  • Reactive Oxygen Species / metabolism
  • Rutin / pharmacology*
  • Vasoconstrictor Agents / toxicity

Substances

  • Antioxidants
  • Reactive Oxygen Species
  • Vasoconstrictor Agents
  • Angiotensin II
  • Nitric Oxide
  • Rutin
  • Quercetin
  • NADPH Oxidases
  • Mitogen-Activated Protein Kinases